Press Releases

CMTA’s Press Room Is Where We Share News That Shapes Not Only the Future of CMT Research but Real Impact Today. From Funding Announcements to Trial Updates, This Is Where Progress Moves From Idea to Action.

CMTA Invests in Armatus Bio

CMTA announced its first investment through its new venture philanthropy arm, participating in a Seed…

Release Date: November 14, 2023

Read This Press Release
CMTA Appoints Suzanne Bruhn, PhD as Chief Executive Officer

CMTA announced the appointment of Suzanne Bruhn, PhD as its new Chief Executive Officer. Bruhn…

Release Date: November 6, 2023

Read This Press Release
CMTA Approves Grant to INC for Clinical Trial Preparation

CMTA approved a $207,018 grant to the Inherited Neuropathy Consortium (INC) to support additional clinical…

Release Date: September 28, 2023

Read This Press Release
CMTA Funds ASO Research Project for CMT2E

CMTA approved a $225,483 research award to Mario Saporta, MD, PhD, at the University of…

Release Date: September 28, 2023

Read This Press Release
CMTA & MDA Jointly Fund Gene Therapy Delivery Approach for CMTX1 (CMT1X/CMTX)

CMTA and MDA announced a joint three-year study evaluating a nanoparticle delivery approach for CMTX1.…

Release Date: September 12, 2023

Read This Press Release
CMTA, European CMT Federation Partner on Research and Awareness

CMTA has formalized its collaboration with the European CMT Federation (ECMTF), becoming a full member…

Release Date: June 30, 2023

Read This Press Release
CMTA Updates Its Neurotoxic Drug List

CMTA has updated its Neurotoxic Drug List following a comprehensive scientific review of medications known…

Release Date: June 22, 2023

Read This Press Release
Tech Entrepreneur Joins CMTA Board of Directors

Tech entrepreneur David Apple has joined the CMTA Board of Directors, bringing a strong business…

Release Date: May 10, 2023

Read This Press Release
CMTA Welcomes Science Writer to Staff

CMTA welcomed Kenneth Raymond to the team as a science writer, bringing a patient-centered perspective…

Release Date: April 26, 2023

Read This Press Release
CMTA Funds Preclinical Study in CMT1B

CMTA has funded a preclinical study exploring whether modulating the unfolded protein response (UPR) can…

Release Date: April 25, 2023

Read This Press Release
Sperm Donor Passes CMT Gene to Multiple Families

A sperm donor unknowingly carrying a gene associated with CMT passed the variant on to…

Release Date: April 20, 2023

Read This Press Release
Drug Development Expert Martine Garnier Joins STAR Advisory Board

CMTA appoints drug development expert Martine Garnier, PhD, EMBA, to its STAR Advisory Board, strengthening…

Release Date: March 30, 2023

Read This Press Release